Traders should prepare for potential volatility around the May 5 earnings release and conference call; monitor management's commentary on pipeline progress and mRNA vaccine development for non-cancer indications.
BNTX drugs
BNTX drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 21 $111.60entry
- T+1 · 7mo ago −2.69%α −3.71% · $108.60
- T+5 · 7mo ago −8.55%α −9.63% · $102.06
- T+20 · 6mo ago −20.39%α −25.30% · $88.85
- T+60 · 4mo ago −17.96%α −24.86% · $91.56
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
BioNTech announced it will release its first-quarter 2026 financial results on May 5, 2026, followed by a conference call and webcast to discuss the results and provide a corporate update. This is a routine earnings announcement with no financial data disclosed.
Key Facts
- BioNTech will announce Q1 2026 financial results on May 5, 2026
- Conference call and webcast scheduled for 8:00 a.m. ET on May 5, 2026
- No financial results or material updates were included in this press release
Financial Impact
No financial impact from this release; actual results will be disclosed on May 5
Risk Factors
- Earnings could miss consensus expectations given recent declines in COVID-related revenue
- Pipeline updates may lack near-term catalysts, leading to investor skepticism
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3277750 |
Track record
38 reports on BNTX
5 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +25.10% at T+20 after the Mar 24, 2026 report. 11 of 16 went positive at some point.
Filters
- Nov 10, 20266d ago 6-K Neutral 4/10 Entry $87.21 Now $85.26 −2.24% settles Feb 8
- Nov 3, 202613d ago 6-K Neutral 5/10 No price data
- Nov 3, 202613d ago 6-K Neutral 5/10 No price data
- Nov 3, 202613d ago Press Release Neutral 5/10 Entry $86.92 Now $85.26 −1.91% settles Feb 1
- Oct 29, 202618d ago Institutional Cluster Mixed 3/10 Entry $89.13 Now $85.26 −4.34% settles Jan 27
- Oct 26, 202621d ago 6-K Bullish 5/10 Entry $86.86 Now $85.26 −1.84% settles Jan 22
- Oct 26, 202621d ago 6-K Bearish 5/10 Entry $86.86 Now $85.26 +1.84% settles Jan 22
- Oct 26, 202621d ago Press Release Bearish 6/10 Entry $86.86 Now $85.26 +1.84% settles Jan 22
- Oct 25, 202622d ago Press Release Bullish 6/10 Entry $86.86 Now $85.26 −1.84% settles Jan 22
- Oct 22, 202625d ago 6-K Neutral 5/10 Entry $89.67 Now $85.26 −4.92% settles Jan 20
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers